I've added to Aphria on the downslope, but didn't think they were heading back to the $3's. Geeezzz
They may post north of $180M in fiscal Q1 to be released mid-Oct. Hopefully they don't have a sequential QoQ decline. If so, they might dip to the low $3s or even $2s.
They already posted $90M last Q from their German subsidiary, CC Pharma. Aphria is clearly the LP leader in Canada and Internationally.
They got a feather in the cap because they walked away from the ACB deal.
We're all hoping for the USA acquisition announcement to generate enthusiasm before the Q.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.